GSH (SGX:BDX) is looking to raise SG$66 million through the issuance of bonds on the SDAX Exchange, according to a Thursday filing with the Singapore Exchange.
The facility comprises several interest bearing issues with tenors ranging between 91 days and 364 days, under the SDAX CP facility program.
Singapore shares shed more than 1% at the close of market on Thursday, tracking regional losses, with investor sentiment taking a hit following the resumption of hostilities between the US and Iran.The Straits Times Index (STI), a key benchmark for the Singapore Exchange, ranged between 5,064.20 and 5,112.09 throughout the day. It ended the session at 5,067.53, down 70.71 points or 1.4% compared to Wednesday's close.On the corporate front, shares of Resources Global Development (SGX:V7R) surged over 9% at the close as it outlined plans to subscribe to its pro-rata entitlement of around 111.8 million shares in Indonesia-listed PT Singaraja Putra (IDX:SINI) for around SG$40 million.The Assembly Place (SGX:TAP) closed over 2% lower after it signed a joint venture agreement with three partners to operate serviced apartments in Tanglin Road, Singapore.Meanwhile, shares of MetaOptics (SGX:9MT) were down nearly 2% despite the semiconductor company confirming the proposed dual listing on the Nasdaq Stock Market to be on track.
Beijing Strong Biotechnologies (SHE:300406) received a medical device registration certificate from the Beijing Municipal Medical Products Administration for an assay kit, according to a Sheznhen bourse filing on Thursday.The certificate is for its fully automated chemiluminescence immunoassay analyzer (Model: Gi 3000).The certificate is valid until May 27, 2031.
Yantai Zhenghai Biotechnology (SHE:300653) renewed its medical device registration certificate for its surgical packing sponge with the Shandong Provincial Medical Products Administration, according to a Shenzhen bourse filing on Thursday.The device is used as a temporary compression after a nasal cavity surgery.The certificate is valid until Dec. 6, 2031.The biotechnology company's shares fell 4% at the close.